Occurrence of HER2 amplification in EGFR-mutant lung adenocarcinoma with acquired resistence to EGFR-TKIs. Predictors of survival for younger patients (pts) less than 50 years of age with non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback